Journal of Neural Transmission

, Volume 104, Issue 4, pp 469–481

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

  • J. Lan
  • D. H. Jiang
Parkinson's Disease and Allied Conditions

DOI: 10.1007/BF01277665

Cite this article as:
Lan, J. & Jiang, D.H. J. Neural Transmission (1997) 104: 469. doi:10.1007/BF01277665


To elucidate the neuroprotective effects of the iron chelator desferrioxamine (DFO) and the antioxidant vitamin E on excessive iron-induced free radical damage, a chronic iron-loaded mice model was established. The relationship between striatal iron content, oxidized to reduced glutathione ratio, hydroxyl radical (.OH) levels and dopamine concentrations were observed in DFO or vitamin E pretreated iron-loaded/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57BL/6 mice. The results demonstrated that both DFO and vitamin E inhibit the iron accumulation and thus reverses the increase in oxidized glutathione (GSSG), oxidized to reduced glutathione ratios, .OH and lipid peroxidation levels. The striatal dopamine concentration was elevated to normal value. Our data suggested that: (1) iron may induce neuronal damage and thus excessive iron in the brain may contribute to the neuronal loss in PD; (2) iron chelators and antioxidants may serve as potential therapeutic agents in retarding the progression of neurodegeneration.


Iron MPTP DFO vitamin E neurodegeneration 

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • J. Lan
    • 1
  • D. H. Jiang
    • 1
  1. 1.Tianjin Neurological InstituteTianjin Medical University HospitalP. R. China
  2. 2.Clinical Neurochemistry, Department of PsychiatryUniversity of WürzburgWürzburgGermany

Personalised recommendations